Recurrent NOMO1 Gene Deletion Is a Potential Clinical Marker in Early-Onset Colorectal Cancer and Is Involved in the Regulation of Cell Migration.

MLA

Pérez-García, Jésica, et al. “Recurrent NOMO1 Gene Deletion Is a Potential Clinical Marker in Early-Onset Colorectal Cancer and Is Involved in the Regulation of Cell Migration.” Cancers, vol. 14, no. 16, Aug. 2022. EBSCOhost, https://doi.org/10.3390/cancers14164029.

APA

Pérez-García, J., Martel-Martel, A., García-Vallés, P., Corchete, L. A., García, J. L., Gestoso-Uzal, N., Vidal-Tocino, R., Blanco, Ó., Méndez, L., Sánchez-Martín, M., Fuentes, M., Herrero, A. B., Holowatyj, A. N., Perea, J., & González-Sarmiento, R. (2022). Recurrent NOMO1 Gene Deletion Is a Potential Clinical Marker in Early-Onset Colorectal Cancer and Is Involved in the Regulation of Cell Migration. Cancers, 14(16). https://doi.org/10.3390/cancers14164029

Chicago

Pérez-García, Jésica, Abel Martel-Martel, Paula García-Vallés, Luis A Corchete, Juan L García, Nerea Gestoso-Uzal, Rosario Vidal-Tocino, et al. 2022. “Recurrent NOMO1 Gene Deletion Is a Potential Clinical Marker in Early-Onset Colorectal Cancer and Is Involved in the Regulation of Cell Migration.” Cancers 14 (16). doi:10.3390/cancers14164029.